Search by Drug Name or NDC

NDC 17856-0312-03 GAVILAX 17 g/17g Details

GAVILAX 17 g/17g

GAVILAX is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by ATLANTIC BIOLOGICALS CORP.. The primary component is POLYETHYLENE GLYCOL 3350.

MedlinePlus Drug Summary

Polyethylene glycol 3350 is used to treat occasional constipation. Polyethylene glycol 3350 is in a class of medications called osmotic laxatives. It works by causing water to be retained with the stool. This increases the number of bowel movements and softens the stool so it is easier to pass.

Related Packages: 17856-0312-03
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Polyethylene Glycol 3350

Product Information

NDC	17856-0312
Product ID	17856-0312_010d26a6-e4ad-4d97-b9d7-17cfd394b11d
Associated GPIs	46600033003020 46600033002910
GCN Sequence Number	034313
GCN Sequence Number Description	polyethylene glycol 3350 POWD PACK 17 G ORAL
HIC3	D6S
HIC3 Description	LAXATIVES AND CATHARTICS
GCN	86211
HICL Sequence Number	022819
HICL Sequence Number Description	POLYETHYLENE GLYCOL 3350
Brand/Generic	Generic
Proprietary Name	GAVILAX
Proprietary Name Suffix	n/a
Non-Proprietary Name	Polyethylene Glycol 3350
Product Type	HUMAN OTC DRUG
Dosage Form	POWDER, FOR SOLUTION
Route	ORAL
Active Ingredient Strength	17
Active Ingredient Units	g/17g
Substance Name	POLYETHYLENE GLYCOL 3350
Labeler Name	ATLANTIC BIOLOGICALS CORP.
Pharmaceutical Class	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA091077
Listing Certified Through	2024-12-31

Package

NDC 17856-0312-03 (17856031203)

Pricing Information	N/A
NDC Package Code	17856-0312-3
Billing NDC	17856031203
Package	17 g in 1 CUP (17856-0312-3)
Marketing Start Date	2021-01-26
NDC Exclude Flag	N